| Kevin D Breniman, MD | |
|
1 Lile Ct, Suite 200, Little Rock, AR 72205-6242 | |
| (501) 224-5500 | |
| (501) 224-1166 |
| Full Name | Kevin D Breniman |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 1 Lile Ct, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659348498 | NPI | - | NPPES |
| 164159001 | Medicaid | AR | |
| 710491322 | Other | AR | UNITED HEALTHCARE |
| 0508812700 | Other | CA | QUALCHOICE |
| 7136217 | Other | AR | AETNA |
| 734687 | Other | AR | HEALTHLINK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VC0200X | Obstetrics & Gynecology - Critical Care Medicine | E4508 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cornerstone Clinic For Women | 5092629352 | 17 |
News Archive
PhotoMedex, Inc. today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Department of Defense (DoD) has recommended STA-9584, a novel vascular disrupting agent (VDA) currently in pre-clinical development at Synta, be funded for study in advanced prostate cancer.
› Verified 9 days ago
| Entity Name | Cornerstone Clinic For Women |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700853553 PECOS PAC ID: 5092629352 Enrollment ID: O20031119000560 |
News Archive
PhotoMedex, Inc. today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Department of Defense (DoD) has recommended STA-9584, a novel vascular disrupting agent (VDA) currently in pre-clinical development at Synta, be funded for study in advanced prostate cancer.
› Verified 9 days ago
| Entity Name | Baptist Medcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699868323 PECOS PAC ID: 5698667624 Enrollment ID: O20040325001348 |
News Archive
PhotoMedex, Inc. today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Department of Defense (DoD) has recommended STA-9584, a novel vascular disrupting agent (VDA) currently in pre-clinical development at Synta, be funded for study in advanced prostate cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin D Breniman, MD 1 Lile Ct, Suite 200, Little Rock, AR 72205-6242 Ph: (501) 224-5500 | Kevin D Breniman, MD 1 Lile Ct, Suite 200, Little Rock, AR 72205-6242 Ph: (501) 224-5500 |
News Archive
PhotoMedex, Inc. today announced that it has regained compliance with the minimum bid price requirement of The Nasdaq Stock Market under Nasdaq Listing Rule 5450(a)(1).
Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.
Nuvo Research Inc., a drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that PENNSAID(R) (diclofenac sodium topical solution) 1.5% w/w, is now available by prescription in U.S. pharmacies.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Department of Defense (DoD) has recommended STA-9584, a novel vascular disrupting agent (VDA) currently in pre-clinical development at Synta, be funded for study in advanced prostate cancer.
› Verified 9 days ago
Dr. Francisco Batres, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 9101 Kanis Rd, Suite 300, Little Rock, AR 72205 Phone: 501-801-1200 Fax: 501-801-1207 | |
Dr. Kristin K Zorn, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
David Hutchins, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Kristen Taylor Bracy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9500 Baptist Health Dr Ste 100, Little Rock, AR 72205 Phone: 501-224-5500 Fax: 501-224-1166 | |
Dayna D Whitcombe, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6119 Midtown Ave, Little Rock, AR 72205 Phone: 501-296-1800 Fax: 501-296-1711 | |
Nafisa Dajani, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 | |
Jennifer Afton Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5 Saint Vincent Cir Ste 300, Little Rock, AR 72205 Phone: 501-552-8800 Fax: 501-552-5343 |